Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult
Michael X. Henderson, Samantha F. Sedor, Ian McGeary, et al.
Neuron (2019) Vol. 105, Iss. 5, pp. 822-836.e7
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Parkinson disease-associated cognitive impairment
Dag Aarsland, Lucia Batzu, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 779
Genetics and Pathogenesis of Parkinson's Syndrome
Hui Ye, Laurie Robak, Meigen Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 95-121
Open Access | Times Cited: 213
The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline
Per Borghammer
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 455-474
Open Access | Times Cited: 169
Parkinson's Disease Genetics and Pathophysiology
Gabriel E. Vázquez-Vélez, Huda Y. Zoghbi
Annual Review of Neuroscience (2021) Vol. 44, Iss. 1, pp. 87-108
Open Access | Times Cited: 156
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith, Anthony H.V. Schapira
Cells (2022) Vol. 11, Iss. 8, pp. 1261-1261
Open Access | Times Cited: 135
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 111
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
Patricia García‐Sanz, Johannes M. F. G. Aerts, Rosario Moratalla
Movement Disorders (2020) Vol. 36, Iss. 5, pp. 1070-1085
Open Access | Times Cited: 89
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
Micol Avenali, Fabio Blandini, Silvia Cerri
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 75
Parkinson's disease outside the brain: targeting the autonomic nervous system
Yehonatan Sharabi, Gad D. Vatine, Avraham Ashkenazi
The Lancet Neurology (2021) Vol. 20, Iss. 10, pp. 868-876
Closed Access | Times Cited: 57
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
Matthew E. Gegg, Elisa Menozzi, Anthony H.V. Schapira
Neurobiology of Disease (2022) Vol. 166, pp. 105663-105663
Open Access | Times Cited: 48
Neuronal activity induces glucosylceramide that is secreted via exosomes for lysosomal degradation in glia
Liping Wang, Guang Lin, Zhongyuan Zuo, et al.
Science Advances (2022) Vol. 8, Iss. 28
Open Access | Times Cited: 42
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
Alexander Hull, Magda L. Atilano, Laith Gergi, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 12
Gaucher disease provides a unique window into Parkinson disease pathogenesis
Ellen Hertz, Yu Chen, Ellen Sidransky
Nature Reviews Neurology (2024) Vol. 20, Iss. 9, pp. 526-540
Closed Access | Times Cited: 11
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Regulation of mitophagy and mitochondrial function: Natural compounds as potential therapeutic strategies for Parkinson's disease
Hao Liang, Zhenwang Ma, Wei Zhong, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 1838-1862
Open Access | Times Cited: 8
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Margaux Teil, Marie-Laure Arotçarena, Emilie Faggiani, et al.
Biomolecules (2020) Vol. 10, Iss. 3, pp. 391-391
Open Access | Times Cited: 55
Animal models of brain-first and body-first Parkinson's disease
Nathalie Van Den Berge, Ayşe Ulusoy
Neurobiology of Disease (2021) Vol. 163, pp. 105599-105599
Open Access | Times Cited: 54
Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation
Changjing Wang, Tongtong Yang, Meiyu Liang, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 48
The Membrane Interactions of Synuclein: Physiology and Pathology
Gautam Runwal, Robert H. Edwards
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 16, Iss. 1, pp. 465-485
Open Access | Times Cited: 43
Wild-type α-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding
Houfang Long, W. Sharon Zheng, Yang Liu, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 20
Open Access | Times Cited: 42
Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders
Marzena Kurzawa‐Akanbi, Seshu R. Tammireddy, Ivo Fabrik, et al.
Acta Neuropathologica (2021) Vol. 142, Iss. 6, pp. 961-984
Open Access | Times Cited: 42
Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
Hilal A. Lashuel, Anne‐Laure Mahul‐Mellier, Salvatore Novello, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 37
A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity
Senthil T. Kumar, Anne‐Laure Mahul‐Mellier, Ramanath Narayana Hegde, et al.
Science Advances (2022) Vol. 8, Iss. 17
Open Access | Times Cited: 30
GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2044-2044
Open Access | Times Cited: 22
Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons
Matthew E. Gegg, Guglielmo Verona, Anthony H.V. Schapira
Human Molecular Genetics (2020) Vol. 29, Iss. 10, pp. 1716-1728
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top